We observed that iHSP110-33 reduced, in a dose-dependent manner, the phosphorylation of STAT6 in PMBL and cHL cell lines as well as in HEK293S6 cells (Fig. 4C and D) and in vivo in K1106P tumor xenografts (Fig. 4E). Here, STAT6 is linked to neoplasm.